Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial

OBJECTIVE: Growth hormone (GH) treatment is known to be effective in increasing stature in children with a short stature born small for gestational age (SGA). This multicentre, randomized, open-label, comparative, phase III study aimed to evaluate the efficacy and safety of Growtropin-II (recombinan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Su Jin, Kim, Min-Sun, Cho, Sung Yoon, Suh, Byung-Kyu, Ko, Cheol Woo, Lee, Kee-Hyoung, Yoo, Han-Wook, Shin, Choong Ho, Hwang, Jin Soon, Kim, Ho-Seong, Chung, Woo Yeong, Kim, Chan Jong, Han, Heon-Seok, Jin, Dong-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322493/
https://www.ncbi.nlm.nih.gov/pubmed/34397702
http://dx.doi.org/10.1097/MD.0000000000026711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322493/
https://www.ncbi.nlm.nih.gov/pubmed/34397702
http://dx.doi.org/10.1097/MD.0000000000026711

Ejemplares similares